Guidelines for breast cancer management in Bosnia and Herzegovina
- PMID: 35880400
- PMCID: PMC9901905
- DOI: 10.17305/bjbms.2022.7504
Guidelines for breast cancer management in Bosnia and Herzegovina
Abstract
Breast cancer is the most common cancer among women. In Bosnia and Herzegovina, accurate data on the status of breast cancer are lacking due to the absence of a central registry. Multiple international guidelines imply that institutions that monitor breast cancer patients should have optimal therapeutic options for treatment. In addition, there have been several international consensus guidelines written on the management of breast cancer. Application of consensus guidelines has previously been demonstrated to have a positive influence on breast cancer care. The importance of specialty breast centers has previously been reported. As part of the 2021 Bosnian-Herzegovinian American Academy of Arts and Sciences (BHAAAS) conference in Mostar, a round table of multidisciplinary specialists from Bosnia and Herzegovina and the diaspora was held. All were either members of BHAAAS or regularly participate in collaborative projects. The focus of the consortium was to write the first multidisciplinary guidelines for the general management of breast cancer in Bosnia and Herzegovina. Guidelines were developed for each area of breast cancer treatment and management. These guidelines will serve as a resource for practitioners managing breast cancer in the Bosnia and Herzegovina region. This might also be of benefit to the ministry of health and any future investors interested in developing breast cancer care policies in this region of the world.
References
-
- World Health Organization. Breast Cancer. Geneva: World Health Organization. 2021. [cited 15 April 2022]. https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
-
- Niksic D, Kurspahic-Mujicic A, Pilav A, Niksic H. Cancer mortality, recent trends and perspectives. Bosn J Basic Med Sci. 2006;6(4):67–71. https://doi.org/10.17305/bjbms.2006.3125. - PMC - PubMed
-
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Breast Cancer, version 2. 2022. [cited 15 April 2022] Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419.
-
- Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, et al. Selecting high priority quality measures for breast cancer quality improvement. Med Care. 2008;46(8):762–70. https://doi.org/10.1097/mlr.0b013e318178ead3. - PMC - PubMed
-
- Hébert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol. 2004;22(18):3685–93. https://doi.org/10.1200/jco.2004.07.018. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials